Differences in the Prognosis according to the Periods of Diagnosis in Ulcerative Colitis | Zendy

Hyun Beom Chae | Zendy; Yoon Suk Jung | Zendy; Dong I.L. Park | Zendy; Chang Kyun Lee | Zendy; Kyu Chan Huh | Zendy; Jeong Eun Shin | Zendy; Jae Hak Kim | Zendy; You Sun Kim | Zendy; Yunho Jung | Zendy; Sung-Ae Jung | Zendy; Hyun Ju Song | Zendy; Hyun Joo Jang | Zendy; Sung Noh Hong | Zendy; Young-Ho Kim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Differences in the Prognosis according to the Periods of Diagnosis in Ulcerative Colitis

Author(s) -

Hyun Beom Chae,

Yoon Suk Jung,

Dong I.L. Park,

Chang Kyun Lee,

Kyu Chan Huh,

Jeong Eun Shin,

Jae Hak Kim,

You Sun Kim,

Yunho Jung,

Sung-Ae Jung,

Hyun Ju Song,

Hyun Joo Jang,

Sung Noh Hong,

Young-Ho Kim

Publication year - 2014

Publication title -

korean journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.203

H-Index - 25

eISSN - 2233-6869

pISSN - 1598-9992

DOI - 10.4166/kjg.2014.64.2.93

Subject(s) - medicine , infliximab , ulcerative colitis , univariate analysis , logistic regression , refractory (planetary science) , group b , population , gastroenterology , surgery , multivariate analysis , disease , physics , environmental health , astrobiology

Infliximab was approved for the treatment of ulcerative colitis (UC) in 2006 and has recently been used as rescue therapy in steroid-refractory UC. The aim of this study was to investigate the differences of medication use and prognosis in UC patients according to the periods of diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research